Literature DB >> 1908824

Effects of activated macrophages on Mycobacterium leprae.

N Ramasesh1, L B Adams, S G Franzblau, J L Krahenbuhl.   

Abstract

Five alternative methods were used to explore in vitro the effects of normal and activated murine macrophages on the metabolic well-being of intracellular Mycobacterium leprae: fluorescein diacetate-ethidium bromide staining, ATP content, synthesis of phenolic glycolipid 1, and two techniques to quantitate oxidation of palmitic acid. In relatively short-term experiments (7 to 10 days), each of these procedures provided strong evidence that activated macrophages exerted a deleterious effect on the leprosy bacillus. These findings appear to confirm the contention that activated macrophages underlie host resistance to clinical leprosy and limitation of M. leprae growth in paucibacillary leprosy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908824      PMCID: PMC258106          DOI: 10.1128/iai.59.9.2864-2869.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Viability of Mycobacterium leprae: a comparison of morphological index and fluorescent staining techniques in slit-skin smears and M. leprae suspensions.

Authors:  O Odinsen; T Nilson; D P Humber
Journal:  Int J Lepr Other Mycobact Dis       Date:  1986-09

2.  In vitro methods for determination of viability of mycobacteria: comparison of ATP content, morphological index and FDA-EB fluorescent staining in Mycobacterium leprae.

Authors:  V M Katoch; K Katoch; G Ramu; V D Sharma; A K Datta; C T Shivannavar; K V Desikan
Journal:  Lepr Rev       Date:  1988-06       Impact factor: 0.537

3.  Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.

Authors:  V M Katoch; K Katoch; U Ramanathan; V D Sharma; C T Shivannavar; A K Datta; V P Bharadwaj
Journal:  Int J Lepr Other Mycobact Dis       Date:  1989-09

4.  Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae.

Authors:  L D Sibley; J L Krahenbuhl
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

5.  Leukocyte antimicrobial function in patients with leprosy.

Authors:  D J Drutz; M J Cline; L Levy
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

6.  Metabolism of Mycobacterium leprae in macrophages.

Authors:  N Ramasesh; R C Hastings; J L Krahenbuhl
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

7.  Adenosine triphosphate content of Mycobacterium leprae isolated from armadillo tissue by Percoll buoyant density centrifugation.

Authors:  J T Kvach; T A Neubert; J C Palomino; H S Heine
Journal:  Int J Lepr Other Mycobact Dis       Date:  1986-03

8.  Biophysical optima for metabolism of Mycobacterium leprae.

Authors:  S G Franzblau; E B Harris
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

9.  Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis.

Authors:  R J Patterson; G P Youmans
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

10.  MYCOBACTERIUM LEPRAE IN MICE: MINIMAL INFECTIOUS DOSE, RELATIONSHIP BETWEEN STAINING QUALITY AND INFECTIVITY, AND EFFECT OF CORTISONE.

Authors:  C C SHEPARD; D H MCRAE
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

View more
  9 in total

1.  Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae.

Authors:  S G Franzblau; A N Biswas; E B Harris
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Mycobacterium leprae is naturally resistant to PA-824.

Authors:  Ujjini H Manjunatha; Ramanuj Lahiri; Baljit Randhawa; Cynthia S Dowd; James L Krahenbuhl; Clifton E Barry
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

3.  Role of inducible nitric oxide synthase in resistance to Mycobacterium leprae in mice.

Authors:  L B Adams; C K Job; J L Krahenbuhl
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

4.  Effects of essential fatty acid deficiency on prostaglandin E2 production and cell-mediated immunity in a mouse model of leprosy.

Authors:  L B Adams; T P Gillis; D H Hwang; J L Krahenbuhl
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

5.  IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians.

Authors:  C C Cardoso; A C Pereira; V N Brito-de-Souza; I M Dias-Baptista; V C Maniero; J Venturini; F R Vilani-Moreno; F C de Souza; M Ribeiro-Alves; E N Sarno; A G Pacheco; M O Moraes
Journal:  Hum Genet       Date:  2010-08-17       Impact factor: 4.132

Review 6.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  Effects of thalidomide on intracellular Mycobacterium leprae in normal and activated macrophages.

Authors:  A Tadesse; E J Shannon
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

8.  Molecular determination of Mycobacterium leprae viability by use of real-time PCR.

Authors:  Alejandra N Martinez; Ramanuj Lahiri; Tana L Pittman; David Scollard; Richard Truman; Milton O Moraes; Diana L Williams
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

9.  Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.

Authors:  Grace L Davis; Nashone A Ray; Ramanuj Lahiri; Thomas P Gillis; James L Krahenbuhl; Diana L Williams; Linda B Adams
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.